![](https://tracker.live.rns-distribution.com/track.live-rns/5288054_d9353a075fe0b610698e373da828b7e4.png)
31 July 2024
SUBSTRATE ARTIFICIAL INTELIGENCE SOCIEDAD ANONIMA
("Substrate AI" or the "Company")
INVESTMENT AGREEMENT
Substrate AI (AQUIS: SAI/SAI.B) announces that it has entered into an investment agreement (the "Agreement") with UNITED GENERAL LTD (the "Investor").
The Agreement will be executed through capital increases for a maximum amount of €2,000,000. The investment commitment expires on 30 July 2025.
The capital increases will relate to the Company's Class A shares and will be carried out in two tranches of up to €1,000,000, at the fixed price based on the closing price on the day immediately prior to the date on which the resolution to increase the capital is passed, with a discount of 10%.
There Agreement does not entail commission costs.
The Directors of the Company accept responsibility for the contents of the announcement.
This announcement contains information which, prior to its disclosure, was inside information as stipulated under Regulation 11 of the Market Abuse (Amendment) (EU Exit) Regulations 2019/310 (as amended). Upon the publication of this announcement via a Regulatory Information Service, this inside information is now considered to be in the public domain.
For further information, please contact:
Substrate AI | |
Lorenzo Serratosa Chairman | accionistas@substrate.ai
|
First Sentinel Corporate Finance Corporate Advisors | |
Brian Stockbridge
| +44 (0) 7858 888 007
|
About Substrate AI: Substrate AI is an artificial intelligence company based in Spain that creates, buys and scales companies around AI in diverse sectors such as fintech, agritech, energy, human resources, or health. All of them sell products and services built on the bio-inspired reinforced learning technology developed and patented by Substrate AI.
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.